Introduction
============

Diabetes mellitus (DM) and its associated complications are major health problems in the developed world. DM is associated with an increased risk of cardiovascular disease (CVD) even in the presence of intensive glycemic control. Indeed, 75% of diabetic patients will die of CVD (Xu and Zou, 2009[@B35]). Diabetic patients have an increased risk for the three major types of macrovascular diseases such as peripheral vascular disease, coronary heart disease, and stroke (Zou et al., 2004[@B37]). Endothelial cells potentially regulate basal vascular tone and reactivity in physiological and pathological conditions. Endothelial dysfunction is the main cause of death and disability in diabetic patients (Capellini et al., 2010[@B5]). Nitric oxide (NO) is one of the most important factors released by endothelium. Diabetes-induced endothelial dysfunction is characterized by reduced bioavailability of NO in the vessel wall. NO, an important regulator of vascular tone, is produced by the activity of endothelial NO synthase (eNOS) (El-Remessy et al., 2010[@B9]) and impaired endothelium-dependent vasodilatation has been well indicated in DM (De Vriese et al., 2000[@B7]).

N. sativa *which* is commonly known as black seed is a plant from the Ranunculaceae family (Ahmad et al., 2013[@B2]). N. sativa extact contains 36--38% fixed oils, 0.4--2.5% essential oil, proteins, and alkaloidsand saponins. The fixed oil is composed mainly of fatty acids such as linoleic (C18:2), palmitic (C16:0), oleic (C18:1), and stearic (C18:0) acids (Nergiz and Otles, 1993[@B25]). Thymoquinone (TQ) is the most pharmacologically active ingredient found abundantly (30-48%) in the N. sativa, together with its derivatives such as dithymoquinone, thymohydroquinone, and thymol (Ghosheh et al., 1999[@B13]).

Several investigations have been shown that N. sativa has a hypoglycemic and antidiabetic effect (Kaleem et al., 2006[@B16]). The Neuroprotective effects of N. sativa *and itsmain constituent have been reported* (Khazdair, 2015[@B18]). On the other hand cardiovascular effects of N. sativa *and itsmain constituent, thymoquinone, such as vasorelaxant (*Niazmand et al., 2014[@B26]*),* antihypertensive (Dehkordi and Kamkhah, 2008[@B8]; Leong et al., 2013[@B20]), hypotensive (Fallah Huseini et al., 2013[@B12]), antihyperlipidemic (Ahmad and Beg, 2013), and ameliorative effect of endothelial dysfunction (El-Saleh et al., 2004[@B10]) were shown. *N. sativa* can reduce the blood glucose levels by stimulated insulin secretion, increased sensitivity to insulin, inhibition of glucose absorption, reduction of advanced glycation end-products (AGE) accumulation, activation of the AMP-activated protein kinase (AMPK) pathway, and increased expression of muscle glucose transporter 4 (Glut4) (Abbasnezhad et al., 2015 in press).

The present study was designed to investigate the effects of hydroalcoholic extract of N. sativa seed on aortic reactivity to vasodilator and vasoconstrictor agents in STZ-induced diabetic rats.

Materials and Methods
=====================

**Plant material and preparation of the extract**

*N. sativa* seeds were purchased from local herbal shop in Mashhad, Khorasan province, Iran and identified by botanists in the herbarium of Ferdowsi University of Mashhad (voucher No. 176-2013-9). The seeds were powdered and soaked in 2 L of a hydroalcoholic solution (50% ethanol, 50% water) for 48 h at room temperature. The extraction solution was subsequently filtered and subjected to evaporation under vacuum at 40 °C until the solvent was evaporated. The dried extract was dissolved in the distilled water to obtain the doses of 100, 200, and 400 mg/kg.

**Chemicals and drugs**

All chemicals were of analytical grade (Merck). PE, ACh, KCl, SNP, and STZ were obtained from Sigma (Germany). Moreover, where needed for all drugs, the Krebs solution was used as the solvent. Plasma glucose was measured using Easygluco glucometer (Korea). Serum cholesterol, triglyceride, LDL, and HDL concentrations were determined using Pars Azmoon kits (Tehran, Iran).

**Animals and induction of diabetes**

Male Wistar rats (250--280 g, 10 weeks old) were housed on a 12 hr light-dark cycle, under constant temperature (22±1 ^o^C) and were allowed free access to standard laboratory diet and drinking water. All experiments were performed under license from the Animal Experimentation Ethics Committee of Mashhad University of Medical Sciences (MUMS).

Diabetes was induced by a single intraperitoneal (IP) injection of STZ (60 mg/kg). Three days after the STZ injection, we confirmed the development of diabetes by measuring fasting blood glucose levels in blood samples taken from tail vein. Rats with blood glucose level≥250 mg/dl were considered to be diabetic.

**Experimental design**

Rats were randomly assigned to six groups (n = 10 in each group): control (C), diabetic (D), diabetic-metformin (DM), diabetic-extract (DE). Normal saline was administered orally by gavage to the C and D groups, metformin (300 mg/kg) to the DM group, and *N. sativa* seed extract (100, 200, and 400 mg/kg) to the DE groups (DE 100, DE 200, and DE 400) daily by gavage for 6 weeks.

**Preparation of rat aortas**

At the end of the treatment period, all rats were euthanized by decapitation with guillotine. The descending thoracic aorta was rapidly dissected out and immersed in 95% O~2~/5% CO~2~-gassed (carbogen) ice-cold Krebs solution (pH 7.4) with the following composition (mM): NaCl (118.0), KCl (4.7), CaCl~2~ (2.5), KH~2~PO~4~ (1.2), MgSO~4~ (1.6), glucose (11.1), and NaHCO~3~(25.0). The aorta was removed free of connective tissue and fat and then cut into ring segments of 2--3 mm in length, and care was taken to avoid any damage to the endothelium. The aortic rings were individually suspended on stainless steel rods in 10 ml organ bath containing Krebs solution gassed with carbogen at 37 ^o^C. After a resting tension of 2 g, the vessel segments were allowed to stabilize for 1 h with the bath fluid being changed every 15 min to prevent metabolite interference. Changes in tension were recorded by isometric transducers connected to a data acquisition system (AD instrument, Australia).

**Experimental procedure**

*Plasma glucose, cholesterol, triglyceride concentrations, and body weight measurements*

Serum fasting blood glucose, cholesterol, and triglyceride concentrations as well as body weight were measured in three different periods of the experiment: before STZ injection, 3 and 24 days after STZ injection (when the diabetes was confirmed), and 6 weeks after STZ injection (day 45).

*Effect of PE and KCl* *on aortic contractile response*

To test the contractile responses of aortic rings, cumulative concentrations of PE (10^-9^ - 10^-5^ M) or KCL (20 - 60 mM) were added to the organ bath and the contraction responses were recorded.

*Effect of Ach and SNP* *on aortic rings dilation response*

To evaluate the vasorelaxant responses of aortic rings, after induction of contraction by PE (10^-6^M), cumulative concentrations of Ach (10^-8^ - 10^-5^ M) or SNP (10^-9^ - 10^-6^ M) were added to the organ bath and the relaxation responses were recorded.

**Data analysis**

Results are expressed as mean±SEM. Statistical analyses were made using one-way ANOVA followed by the Tukey's post hoc test. Statistical significance was defined as p\<0.05.

Results
=======

**Body weight and plasma glucose, cholesterol, and triglyceride in STZ-induced diabetic and control rats**

The results showed significant weight loss at days 24 and 45 in the diabetic group compared to control group (p\<0.001) but in the metformin group, no significant change was observed compared to diabetic group. The weight average at days 24 and 45 in group of DE 400 was less than group of DE 200 ([Table 1](#T1){ref-type="table"}). Serum fasting blood glucose levels at days 3, 24, and 45 in the untreated diabetic group were significantly different from control group (p\<0.001). In the metformin group, glucose level in these periods was not different compared to diabetic group. Our results showed that serum glucose levels in group DE 200 at days 24 and 45 were significantly lower than diabetic group (p\<0.05) ([Table 1](#T1){ref-type="table"}).

###### 

Effect of*N. sativa*seed extract on average weight (g) and serum glucose levels (mg/dl) in streptozotocin-induced diabetic rats

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Group**                  **Weight**                                 **Glucose**                                                                       
  ------------ ------------- -------------- -------------- ------------ -------------- ------------------------------------------------------------------ --------------
  **C**        286.37±428    301.62±4.74    315.12±3.98    86.10±2.62   86.10±2.62     87.38±4.31                                                         84.48±3.96

  **D**        278.95±5.7    243.48±6.93    231.43±8.11    82±2.11      335.2±17.54    293.39±7.82                                                        300.54±10.40

  **DM**       280.16±5.51   253±4.56       235.5±5.88     98.46±1.67   302.43±10.32   278.99±26.11                                                       267.60±21.31

  **DE 100**   273.55±3.95   237.66±7.41    227.22±5.87    97.81±3.91   307.11±13.32   248.56±13.15                                                       238.92±28.59

  **DE 200**   292.45±4.80   258.54±9.77    244.81±10.48   91.91±5.89   347.33±8.69    190.99±21.28\                                                      168.75±24.32
                                                                                       [\*](#TFN1){ref-type="table-fn"}[\#](#TFN4){ref-type="table-fn"}   

  **DE 400**   282.57±7.75   230.28±13.41   217.85±11.55   91.65±4.05   334.24±5.30    258.74±28.72                                                       227.47±27.40
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: C: control, D: diabetic, DM: diabetic + metformin, DE 100: diabetic + *N. sativa*extract of 100 mg/kg, DE 200: diabetic + *N. sativa*extract of 200 mg/kg, DE 400: diabetic + *N. sativa*extract of 400 mg/kg. Values are presented as means±SEM (n = 8).

p\<0.05,

p\<0.01 and

p\<0.001 compared to control group.

p\<0.01,

p\<0.001 and

p\<0.001 compared to diabetic group.

Serum cholesterol levels at days 24 and 45 in the untreated diabetic group were significantly higher than control group (p\<0.001). Moreover, cholesterol levels showed significant decrease in all other treated groups compared to untreated diabetic group (p\<0.05 to p\<0.001) ([Table 2](#T2){ref-type="table"}). The results showed significant increase of serum triglyceride levels of diabetic groups compared to the control group at days 24 and 45 (p\<0.001). Between treated groups at day 24, this level was decreased only in DE 200 compared to diabetic group (p\<0.05) but at day 45 triglyceride levels of all extract-treated groups showed a significant decrease in comparison to the diabetic group (p\<0.001 for all) ([Table 2](#T2){ref-type="table"}).

###### 

Effect *of N. sativa*seed extract on average serum levels of cholesterol and triglyceride (mg/dl) in streptozotocin-induced diabetic rats

  **Group**                 **Cholesterol**                                                                                                                                                                                  **Triglyceride**
  ------------ ------------ ------------------------------------------------- ------------------------------------------------- ------------- ------------------------------------------------------------------------------ --------------------------------------------------
  **C**        71.91±2.83   73.66±1.21                                        72.63±4.17                                        55.42±2.58    87.38±4.31                                                                     56.43±2.44
  **D**        76.05±1.29   108.62±1.7[\*\*\*](#TFN8){ref-type="table-fn"}    121.42±6.66[\*\*\*](#TFN8){ref-type="table-fn"}   61.91 ±6.40   293.39±7.82[\*\*\*](#TFN8){ref-type="table-fn"}                                101.34±2.96[\*\*\*](#TFN8){ref-type="table-fn"}
  **DM**       73±2.23      89.38±3.63[\#\#\#](#TFN10){ref-type="table-fn"}   82.27±3.23[\#\#\#](#TFN10){ref-type="table-fn"}   64.80±6.4     278.99±26.11[\*\*\*](#TFN8){ref-type="table-fn"}                               267.60±21.31[\*\*\*](#TFN8){ref-type="table-fn"}
  **DE 100**   70.07±3.79   87.43±4.22[\#](#TFN9){ref-type="table-fn"}        78.87±2.84[\#\#\#](#TFN10){ref-type="table-fn"}   65.03±5.56    248.56±13.15[\*\*\*](#TFN8){ref-type="table-fn"}                               60.48±5.21[\#\#\#](#TFN10){ref-type="table-fn"}
  **DE 200**   71.54±2.05   87.55±2.16[\#\#\#](#TFN10){ref-type="table-fn"}   86.25±3.22[\#\#\#](#TFN10){ref-type="table-fn"}   56.54±2.49    190.99±21.28[\*](#TFN7){ref-type="table-fn"}[\#](#TFN9){ref-type="table-fn"}   68.41±5.03[\#\#\#](#TFN10){ref-type="table-fn"}
  **DE 400**   67.08±2.25   84.45±6.01[\#\#\#](#TFN10){ref-type="table-fn"}   80.60±5.60[\#\#\#](#TFN10){ref-type="table-fn"}   63.05±4.44    258.74±28.72[\*\*\*](#TFN8){ref-type="table-fn"}                               65.82±17.28[\#\#\#](#TFN10){ref-type="table-fn"}

Abbreviations: C: control, D: diabetic, DM: diabetic + metformin, DE 100: diabetic + *N. sativa*extract of 100 mg/kg, DE 200: diabetic + *N. sativa*extract of 200 mg/kg, DE 400: diabetic + *N. sativa*extract of 400 mg/kg. Values are presented as means±SEM (n = 8).

p\<0.05,

p\<0.001 compared to control group and

p\<0.05,

p\<0.001 compared to diabetic group.

**The contractile responses of aortic rings to phenylepherine**

The contractile responses of aortic rings to cumulative concentrations of PE (10^-9^ to 10^-5^ M) were shown in [Figure 1](#F1){ref-type="fig"}. The lower concentrations of *N. sativa* seed extract (DE 100 and DE 200) and metformin significantly reduced the contractile responses to higher concentrations of PE (10^-6^- 10^-5^M) compared to diabetic group (p\<0.05 to p\<0.01) ([Figure 1](#F1){ref-type="fig"}).

**The contractile responses of aortic rings to KCl**

The cumulative concentrations of KCl (20-60 mM) increased the contractile responses of aortic rings concentration-dependently which were not significantly different between the groups ([Figure 2](#F2){ref-type="fig"}).

![The contractile response of aortic rings to cumulative concentrations of phenylepherine (10^-9^ - 10^-5^ M) in control (C), diabetic (D), *N. sativa*seed extract (DE 100, DE 200, and DE 400), and metformin (DM) treated groups. Values are presented as means±SEM (n = 8). \* p\<0.05, \*\* p\<0.01 compared to diabetic group and ^+^p\<0.05 compared to control group](AJP-6-067-g001){#F1}

![The contractile response of aortic rings to cumulative concentrations of KCL (20-60 mM) in control (C), diabetic (D), *N. sativa*seed extract (DE 100, DE 200, and DE 400), and metformin (DM) treated groups. Values are presented as means±SEM (n = 8). \* p\<0.05, \*\*\* p\<0.001 compared to diabetic group and ^+^p\<0.05 compared to control group](AJP-6-067-g002){#F2}

**The relaxation responses of aortic rings to acetylcholine**

In aortic rings pre-contracted with PE, Ach relaxation was impaired in diabetic group compared to those from normal rats. The highest relaxation responses of aortic rings were observed in DE 200 and DM groups. The relaxation response to Ach 10^-8^ M, was increased in DE 200 and metformin groups compared to diabetic group (p\<0.05). The relaxation responses to Ach 10^-7^**-**10^-5^ M, were significantly higher in all treated groups compared to diabetic group (p\<0.05 to p\<0.001) ([Figure 3](#F3){ref-type="fig"}).

**The relaxation responses of aortic rings to** **sodium nitroprusside**

In aortic rings pre-contracted with PE, the relaxation responses to SNP (10^-9^ - 10^-6^ M) were not significantly different between the groups ([Figure 4](#F4){ref-type="fig"}).

![The relaxation responses of aortic rings to cumulative concentrations of acetylcholine (10^-8^ - 10^-5^ M) in control (C), diabetic (D), *N. sativa*seed extract (DE 100, DE 200, and DE 400), and metformin (DM) treated groups. Values are presented as means±SEM (n=8). \*p\<0.001, \*\*\* p\<0.001 compared to diabetic group and ^+^ p\<0.05, ^+++^ p\<0.001 compared to control group](AJP-6-067-g003){#F3}

![The relaxation responses of aortic rings to cumulative concentrations of sodium nitroprusside (10^-9^ - 10^-6^ M) in control (C), diabetic (D), *N. sativa*seed extract (DE 100, DE 200, and DE 400), and metformin (DM) treated groups. Values are presented as means±SEM (n = 8](AJP-6-067-g004){#F4}

Discussion
==========

The results of the present study indicate that chronic administration of *N. Sativa* seed extract has a significant hypoglycemic effect and improves aortic reactivity to vasoconstrictor and vasodilatation agents in STZ-induced diabetic rats. Previous studies demonstrated that enhanced vascular reactivity to vasoconstrictor agents (Pinho et al., 2010[@B29]) or impairment of the vasodilation (Csanyi et al., 2007[@B6]) contributes to the cardiovascular complications associated with DM. Promoted vascular reactivity to ~1~ adrenoreceptor agonists was indicated in different vascular beds from diabetic animals (Abebe et al., 1990[@B1]). The increased aortic contractile responses of diabetic rats may be due to impaired endothelial function (Potenza et al., 2009[@B30]), increased calcium influx through voltage-dependent L-type Ca^2+^ channels (Pinho et al., 2010[@B29]), increased myofilament Ca^2+^ sensitivity (Kizub et al., 2010[@B19]), increased vasoconstrictor prostanoids due to increased superoxide anions, and increased sensitivity to adrenergic agonists (Ahmad and Beg, 2013[@B2]) and oxidative stress (Tabit et al., 2010[@B33]).

PE, an adrenoreceptor agonist, causes aortic contraction by Ca^2+^ influx via receptor-operated Ca2+ channels (ROCCs) and by release of Ca^2+^ from the sarcoplasmic reticulum (Thorneloe and Nelson, 2005[@B34]; McCarron et al., 2003[@B24]). The latter pathway involves PE stimulation of phospholipase C to produce diacylglycerol (DG) and 1,4,5 triphosphate inositol (IP~3~), and subsequently DG activates the light chain of myosin by activation of protein kinase C (PKC), and IP~3~ induces Ca^2+^ release from the sarcoplasmic reticulum through opening IP~3~ receptors (Thorneloe and Nelson, 2005[@B34]).

Results of previous studies have shown that the voltage-dependent Ca^2+^ channels (VDCCs) are involved in KCl-induced contraction. Our previous study showed the relaxant effect of *N. sativa* seed on the contractions induced by PE and KCl in VSMCs are mediated by inhibition of extracellular Ca^2+^ influx and also suppression of IP~3~-mediated receptors (Niazmand et al., 2014[@B26]). Thus, the *N. sativa* effect on PE and KCl-induced vasoconstriction of diabetic rat aortic rings may be due to these effects.

In endothelial cells of most vascular beds, Ach can stimulate formation and release of endothelial-derived relaxing factors including NO, prostacyclin, and endothelium-derived hyperpolarizing factor. This pathway causes the relaxation of vascular smooth muscle in an endothelium-dependent manner (Zhang et al., 2011[@B36]). The Ach-induced relaxation response is endothelium-dependent and NO-mediated. The results of the present study revealed that the relaxant response was reduced in aortas from STZ-induced diabetic rats and this reduced relaxation was profoundly recovered by *N. sativa* seed treatment. The impairment of Ach-induced relaxation suggests a possible common pathophysiologic mechanism that there is an attenuation of NO release in the diabetic group, thus *N. sativa* seed may improve NO pathway in endothelial cells in diabetic rats.

Impaired endothelium-dependent relaxation in STZ-induced diabetic rat might be due to enhance blood glucose level and reduce blood insulin level. It has been shown that hyperglycemia leads to tissue damage by several mechanisms, including the advanced glycation end product (AGE) formation, increased polyol pathway flux, apoptosis, and reactive oxygen species (ROS) formation (Hartge et al., 2007[@B14]). Our results showed that *N. sativa* treatment could exert a significantly hypoglycemic and hypolipidemic effects in STZ-induced diabetic rats. Therefore, its beneficial effect on aortic tissue of diabetic rats should be in part due to its hypoglycemic and hypolipidemic effects. Since the dosage of 200 mg/kg of *N. sativa* extract had the most beneficial effects on reducing blood glucose level, this hypoglycemic effect may be accompanied with decrease of AGE and explain the higher recovery of relaxant response in this case. Some damaging effects of diabetes on vascular tissue of diabetic animals are also believed to be due to promoted oxidative stress (Paneni et al., 2013[@B28]). The initial trigger, i.e., high glucose concentrations change vascular function, is the imbalance between NO bioavailability and accumulation of ROS, which leads to endothelial dysfunction. Indeed, hyperglycemia-induced production of superoxide anion (O~2~^-^) inactivates NO to form peroxynitrite (ONOO^-^), a potent oxidant which easily penetrates across phospholipid membranes and induces substrate nitration (Luscher et al., 2003[@B22]). The seed of *N. sativa* is well known for its powerful antioxidant properties (Ismail et al., 2010[@B15]). Therefore, the other possible mechanism is the ability of *N. sativa* seed to reduce diabetic-induced oxidative stress damage on vascular tissues.

In this study, we also evaluated the vascular effect of SNP, a general NO donor and an endothelium-independent vasodilator. The relaxation responses to SNP were similar and there was insignificant difference between our experimental groups. The majority of previous studies support our finding that the response of the tissue to SNP is not impaired in diabetics versus control (Elcioglu et al., 2010[@B11]; Oyama et al., 1986[@B27]).

Metformin is a classic drug for DM treatment. Previous studies have shown that metformin therapy was favorable for cardiovascular outcomes and the mechanisms might be partially related with its effects on improving insulin resistance, reducing serum level of C-reactive protein (CRP), enhancing eNOS expression and NO production, improving glycation and oxidative stress, and regulating glucose metabolism (Sena et al., 2011[@B32]; Calvert et al., 2008[@B4]; Liu et al., 2014[@B21]).

In the present study, although metformin treatment of STZ diabetic rats did not correct their increased blood glucose level, the altered responses to the vasoactive agents tested were corrected. Similar data were obtained in previous studies (Katakam et al., 2000[@B17]; Majithiya and Balaraman, 2006[@B23]; Sartoretto et al., 2005[@B31]) that demonstrated improved vascular reactivity to endothelium-dependent vasodilator, acetylcholine, in diabetic rats after treatment with metformin. Metformin improved aortic reactivity of diabetic rats, which may be attributed to improved glycation and antioxidant defense and diminished Rho kinase activity. In diabetic preparations, involment of RhoA/Rho-kinase (ROCK) pathway in the mechanical activity of arteries via an increase in active RhoA-kinase level and decreases in both eNOS expression and NO production by endothelium has already been shown with the previously published data (Kizub et al., 2010[@B19]; El-Saleh et al., 2004[@B10]).

Our study demonstrated that chronic administration of *N. sativa* seed extract has a significant hypoglycemic effect and improved aortic reactivity to vasoconstrictor and vasodilator agents in STZ-induced diabetic rats.
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